Cannabis Law Report

JULY 28, 2021

We believe in diversity and inclusion of people of all backgrounds, genders, races, ethnicities, sexual orientations, educational backgrounds, military and veteran status,?religions, QC study data output files and raw datasets into data tables for regulatory documents as needed. Experience working for a clinical study Sponsor.

Clinical Trials 105

Clinical Trials Research and Development Data Environment 105

Cannabis Law Report

JUNE 10, 2021

The Traffic Safety Culture Index is an annual survey with national scope and multiple measures relevant to driving after marijuana use. Because THC presence is an imperfect proxy for impairment [ 10 ], driving data may be limited in clarifying what traffic safety risks, if any, are associated with permissive marijuana policies.

Policy 59

Policy Safety Marijuana Data 59

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. MAPS completed the first Phase 1 safety study with MDMA and resumed working on a protocol for anxiety associated with cancer.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Veriheal

AUGUST 31, 2020

At Veriheal, education and diversity are at the center of our core values. Choosing only 10 winners for the $10,000 in scholarships among the strong applications we received from multiple disciplines and concentrations in higher education—from students of all backgrounds and interests—was extremely difficult.

Research and Development 117

Research and Development Education Agriculture Patients 117

The Cannigma

AUGUST 31, 2021

Medical societies are slowly providing more CME (continuing medical education) to doctors on cannabis, however, that educational content tends to be slanted toward risk mitigation. Fortunately, there is a slowly growing community of cannabis physicians who are learning through trial and error and from one another.

Education 101

Education Clinical Trials Medicine Policy 101

The Cannigma

DECEMBER 14, 2021

There are no published studies on the efficacy or safety of HHC in human subjects but that has not stopped some manufacturers from producing and selling HHC products. This would indicate that similar to THC, HHC is metabolized in humans to 11-hydroxy-HHC which could in part be responsible for the psychoactive effects of HHC when consumed.

Research and Development 116

Research and Development Cannabinoids Clinical Trials THC 116

Cannabis Law Report

DECEMBER 7, 2021

Despite the massive and growing market size, there is still scant data on the effectiveness of over-the-counter cannabinoid products due to the cost, speed and scale limitations of the current approach to scientific research,” said Jeff Chen, MD/MBA, Co-founder and CEO of Radicle Science. in less than four days.

Clinical Trials 52

Clinical Trials CBD Data Sleep 52

TheAnswerPage

JANUARY 11, 2022

As the Editor-in-Chief of the medical education website called TheAnswerPage.com for nearly two decades, I have assessed multiple educational gaps in the healthcare community. Thus, an educational gap developed, creating a less than ideal situation for medical marijuana patients. So, why did this educational gap develop?

Patients 98

Patients Education Marijuana Therapy 98

Miss Marijuana

JUNE 30, 2019

As the industry leader, we are committed to advancing research and education to help more and more consumers realize the many benefits of hemp CBD supplementation.”. So what’s next? Our health and wellness depends on it!

Sleep 72

Sleep CBD Clinical Trials Oil 72

Cannabis Law Report

JULY 21, 2022

The comprehensive legislation would end federal cannabis prohibition by removing cannabis from the Controlled Substances Act; empower states to create their own cannabis laws; ensure federal regulation protects public health and safety; and prioritize restorative and economic justice .

Safety 52

Safety Legislation Clinical Trials Banking 52

Cannabis Law Report

DECEMBER 2, 2021

Under the approved recommendations, students applying for psilocybin training programs are required to provide a description of their educational background and a written statement explaining their commitment and interest in becoming a psilocybin facilitator. Safety, Ethics and Responsibilities of a Psilocybin Facilitator (10 Hours).

Law 52

Law Programs Therapy Education 52

Cannabis Law Report

MARCH 29, 2020

At an HIV Community Cannabis Education event held in Toronto, a cannabis company proudly declared their company had not had a single product recall to date. triggering new innovations and improved data quality through better user experiences. Product Quality in Manufacturing. These are the responsibility of the manufacturer.

Compliance 69

Compliance Compliance Supply Chain Research and Development 69

Cannabis Law Report

JULY 28, 2021

The results also provide confidence in the Company’s plan to dedicate resources to advance PD-001 through FDA IND-enabling studies to support Phase 1 and 2 clinical studies. The Company also owns 100% of Super Smart, a Dutch company building a modern adult use psychedelic retail business with an elevated and educational focus.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Puff Puff Post

DECEMBER 28, 2018

An official study is aimed to conclude in July of 2019, where we’ll see all the data which comes forth. Beyond alternative therapies, education and medication are the two most accepted ways of treating autism. Most education-based autism treatment is focused on teaching developing children self-care, communicative, and social skills.

Treatment 76

Treatment Oil CBD Therapy 76

The Cannigma

JUNE 15, 2021

However, the scientific data on CBG is nowhere near as developed as what we have on CBD. The vast majority of what we know about CBD’s medicinal effects is based on laboratory studies, is far from being properly understood, and lacks solid scientific data on human subjects — aside from epilepsy 5. Kevin McGovern/Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

MAY 13, 2019

Screening for relevancy, full-text review, data extraction, and risk of bias were completed by two independent investigators. Data Availability: All relevant data are within the paper and its Supporting Information files. Pre-defined inclusion and exclusion criteria were applied uniformly.

Medicine 45

Medicine Research and Development Clinical Trials Data 45

The Cannigma

APRIL 8, 2021

With cannabis, Dr. Peterson, continues, your best source of education is often a budtender with nothing more than a high school education. They can only refer you, and then you get sent to someone with potentially just a high school education. “The law states, you must be ensured the opportunity to speak with someone like me.”

Medicine 108

Medicine Cannabinoids Cannabis THC 108

The Cannigma

DECEMBER 22, 2021

Listen & Subscribe: Israel is world-renowned for the research and innovation that is taking place there, and unofficial data suggests that around 20% of the Israeli population uses cannabis. We do participate in clinical trials that are initiated by others, and we will have our own clinical trial using terpene formulations in oil.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. Data collection.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JUNE 4, 2021

Through his social media outlets, podcast, blog, and interviews, Tim has educated hundreds of millions of people about psychedelics. Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51